BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 2393266)

  • 21. Comparisons of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-azido-3'-deoxythymidine.
    Kong XB; Zhu QY; Vidal PM; Watanabe KA; Polsky B; Armstrong D; Ostrander M; Lang SA; Muchmore E; Chou TC
    Antimicrob Agents Chemother; 1992 Apr; 36(4):808-18. PubMed ID: 1503443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
    J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
    Meng Q; Su T; O'Neill JP; Walker VE
    Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
    Chang S; Griesgraber GW; Southern PJ; Wagner CR
    J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus.
    Mansuri MM; Hitchcock MJ; Buroker RA; Bregman CL; Ghazzouli I; Desiderio JV; Starrett JE; Sterzycki RZ; Martin JC
    Antimicrob Agents Chemother; 1990 Apr; 34(4):637-41. PubMed ID: 1693057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro anti-human immunodeficiency virus and anti-hepatitis B virus activities and pharmacokinetic properties of heterodinucleoside phosphates containing AZT or ddC.
    Peghini PA; Zahner R; Kuster H; Schott H; Schwendener RA
    Antivir Chem Chemother; 1998 Mar; 9(2):117-26. PubMed ID: 9875383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of Tk and Hprt lymphocyte mutants and bone marrow micronuclei in mice treated neonatally with zidovudine and didanosine.
    Von Tungeln LS; Dobrovolsky VN; Bishop ME; Shaddock JG; Heflich RH; Beland FA
    Mutagenesis; 2004 Jul; 19(4):307-11. PubMed ID: 15215330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the sensitivities of primary isolates of HIV type 2 and HIV type 1 to antiviral drugs and drug combinations.
    Cox SW; Apéria K; Albert J; Wahren B
    AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1725-9. PubMed ID: 7888232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antiviral activity of 3'-azido-3'-deoxythymidine triphosphate distearoylglycerol: a novel phospholipid conjugate of the anti-HIV agent AZT.
    van Wijk GM; Hostetler KY; Kroneman E; Richman DD; Sridhar CN; Kumar R; van den Bosch H
    Chem Phys Lipids; 1994 Apr; 70(2):213-22. PubMed ID: 8033292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.
    Medina DJ; Hsiung GD; Mellors JW
    Antimicrob Agents Chemother; 1992 May; 36(5):1127-30. PubMed ID: 1510405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate esters of 3'-azido-3'-deoxythymidine.
    Rosowsky A; Saha J; Fazely F; Koch J; Ruprecht RM
    Biochem Biophys Res Commun; 1990 Oct; 172(1):288-94. PubMed ID: 2222476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple-drug-resistant mutants of feline immunodeficiency virus selected with 2',3'-dideoxyinosine alone and in combination with 3'-azido-3'-deoxythymidine.
    Gobert JM; Remington KM; Zhu YQ; North TW
    Antimicrob Agents Chemother; 1994 Apr; 38(4):861-4. PubMed ID: 8031060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of the SOS response in Escherichia coli by azidothymidine and dideoxynucleosides.
    Mamber SW; Brookshire KW; Forenza S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1237-43. PubMed ID: 2118327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection and rescue from 2',3'-dideoxypyrimidine nucleoside analog toxicity by hemin in human bone marrow progenitor cells.
    Fowler DA; Xie MY; Sommadossi JP
    Antimicrob Agents Chemother; 1996 Jan; 40(1):191-5. PubMed ID: 8787904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus inhibition is prolonged by 3'-azido-3'-deoxythymidine alternating with 2',3'-dideoxycytidine compared with 3'-azido-3'-deoxythymidine alone.
    Spector SA; Ripley D; Hsia K
    Antimicrob Agents Chemother; 1989 Jun; 33(6):920-3. PubMed ID: 2548440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro toxicity of A 3'-azido-3'-deoxythymidine and hydroxyurea combination on normal myeloid progenitors.
    Lerza R; Castello G; Ballarino P; Mela GS; Tredici S; Arboscello E; Mencoboni M; Pannacciulli I
    Anticancer Res; 1998; 18(4A):2755-8. PubMed ID: 9703941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of drug-resistant variants of human immunodeficiency virus type 1 by in vitro passage in increasing concentrations of 2',3'-dideoxycytidine and 2',3'-dideoxy-3'-thiacytidine.
    Gao Q; Gu Z; Hiscott J; Dionne G; Wainberg MA
    Antimicrob Agents Chemother; 1993 Jan; 37(1):130-3. PubMed ID: 8381634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracellular activation and cytotoxicity of three different combinations of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine.
    Palmer S; Cox S
    AIDS Res Hum Retroviruses; 1995 Oct; 11(10):1227-33. PubMed ID: 8573379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs.
    McIntee EJ; Remmel RP; Schinazi RF; Abraham TW; Wagner CR
    J Med Chem; 1997 Oct; 40(21):3323-31. PubMed ID: 9341906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective protection of toxicity of 2',3'-dideoxypyrimidine nucleoside analogs by beta-D-uridine in human granulocyte-macrophage progenitor cells.
    Faraj A; Schinazi RF; Xie MY; Gosselin G; Perigaud C; Imbach JL; Sommadossi JP
    Antiviral Res; 1996 Mar; 29(2-3):261-7. PubMed ID: 8739604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.